表紙
市場調査レポート

アデノウィルス感染症:世界の治験レビュー

Adenovirus Infections Global Clinical Trials Review, H1, 2013

発行 GlobalData 商品コード 244206
出版日 ページ情報 英文 84 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.75円で換算しております。
Back to Top
アデノウィルス感染症:世界の治験レビュー Adenovirus Infections Global Clinical Trials Review, H1, 2013
出版日: 2013年06月30日 ページ情報: 英文 84 Pages
概要

当レポートでは、世界のアデノウィルス感染症治療薬の臨床試験について調査し、 地域別の臨床試験数データ、試験段階、試験状況、採用テーマおよびスポンサー企業タイプ別の臨床試験データ、 中断(一時中止、廃止、打ち切り)された試験のリストなどを提供しており、 概略以下の構成でお届けします。

目次

  • イントロダクション
    • アデノウィルス感染症
    • レポートガイダンス
  • 臨床試験:地域別
  • 臨床試験:国別
    • 臨床試験に寄与している主要国 − 欧州
    • 臨床試験に寄与している主要国 − 北米
    • 臨床試験に寄与している主要国 − 中南米
  • 臨床試験 BRIC 諸国
  • 臨床試験 G7 諸国
  • 臨床試験 G7 諸国 , 治験ステータス別
  • 臨床試験 E7 諸国
  • 臨床試験 E7 諸国 , 治験ステータス別
  • 相別臨床試験
    • 進行中の治験:相別
  • 臨床試験:治験ステータス別
  • 期間ごとの被験者数
  • 有力なスポンサー
    • 主な治験参加企業
  • 有望な治療薬比較
  • 臨床試験プロファイル
    • 臨床試験概要: 主要企業
      • Adapt Produtos of talmologicos Ltda
      • Romark Laboratories, L.C.
      • Cell Medica Limited
      • Teva Pharmaceutical Industries Limited
      • ViraCor Laboratories
      • Qiagen N.V.
    • 臨床試験概要: トップレベルの大学 / 研究機関 / 病院
      • Baylor College of Medicine
      • 大阪市立大学
      • 東京大学病院
      • Medical College of Wisconsin
      • Federal University of Sao Paulo
      • Assistance Publique - Hopitaux de Paris
  • 5大臨床プロファイル

付録

図表一覧


このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC1685CTIDB

Summary

GlobalData's clinical trial report, "Adenovirus Infections Global Clinical Trials Review, H1, 2013" provides data on the Adenovirus Infections clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Adenovirus Infections. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Adenovirus Infections. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Adenovirus Infections
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by BRIC Nations
  • Clinical Trials by G7 Nations
  • Clinical Trials in G7 Nations by Trial Status
  • Clinical Trials by E7 Nations
  • Clinical Trials in E7 Nations by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Subjects Recruited Over a Period of Time
  • Prominent Sponsors
    • Top Companies Participating in Adenovirus Infections Therapeutics Clinical Trials
  • Prominent Drug Comparison
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Chimerix, Inc.
      • Clinical Trial Overview of Chimerix, Inc.
      • Cell Medica Limited
      • Clinical Trial Overview of Cell Medica Limited
      • NovaBay Pharmaceuticals, Inc.
      • Clinical Trial Overview of NovaBay Pharmaceuticals, Inc.
      • Adapt Produtos Oftalmologicos Ltda
      • Clinical Trial Overview of Adapt Produtos Oftalmologicos Ltda
      • Romark Laboratories, L.C.
      • Clinical Trial Overview of Romark Laboratories, L.C.
      • Teva Pharmaceutical Industries Limited
      • Clinical Trial Overview of Teva Pharmaceutical Industries Limited
      • Viracor-IBT Laboratories, Inc.
      • Clinical Trial Overview of Viracor-IBT Laboratories, Inc.
      • Qiagen N.V.
      • Clinical Trial Overview of Qiagen N.V.
    • Clinical Trial Overview of Top Institutes / Government
      • Baylor College of Medicine
      • Clinical Trial Overview of Baylor College of Medicine
      • The National Institute of Allergy and Infectious Diseases
      • Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases
      • Lifelong Vision Foundation
      • Clinical Trial Overview of Lifelong Vision Foundation
      • Osaka City University
      • Clinical Trial Overview of Osaka City University
      • The University of Tokyo Hospital
      • Clinical Trial Overview of The University of Tokyo Hospital
      • Medical College of Wisconsin
      • Clinical Trial Overview of Medical College of Wisconsin
      • Federal University of Sao Paulo
      • Clinical Trial Overview of Federal University of Sao Paulo
      • Assistance Publique - Hopitaux de Paris
      • Clinical Trial Overview of Assistance Publique - Hopitaux de Paris
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Adenovirus Infections Therapeutics Market, Global, Clinical Trials by Zone, 2013*
  • Adenovirus Infections Therapeutics Market, Global, Clinical Trials by Top Countries, 2013*
  • Adenovirus Infections Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013*
  • Adenovirus Infections Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2013*
  • Adenovirus Infections Therapeutics Clinical Trials, Europe, Top Countries, 2013*
  • Adenovirus Infections Therapeutics Clinical Trials, North America, Top Countries, 2013*
  • Adenovirus Infections Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2013*
  • Adenovirus Infections Therapeutics Clinical Trials, Central and South America, Top Countries, 2013*
  • Adenovirus Infections Therapeutics Clinical Trials, BRIC Countries, 2013*
  • Adenovirus Infections Therapeutics Clinical Trials, G7 Countries, 2013*
  • Adenovirus Infections Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013*
  • Adenovirus Infections Therapeutics Clinical Trials, E7 Countries, 2013*
  • Adenovirus Infections Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013*
  • Adenovirus Infections Therapeutics Market, Global, Clinical Trials by Phase, 2013*
  • Adenovirus Infections Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013*
  • Adenovirus Infections Therapeutics Market, Global, Clinical Trials by Trial Status, 2013*
  • Adenovirus Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012
  • Adenovirus Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2013*
  • Adenovirus Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013*
  • Adenovirus Infections Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013*
  • Adenovirus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Chimerix, Inc., 2013*
  • Adenovirus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Cell Medica Limited, 2013*
  • Adenovirus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by NovaBay Pharmaceuticals, Inc., 2013*
  • Adenovirus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Adapt Produtos Oftalmologicos Ltda, 2013*
  • Adenovirus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Romark Laboratories, L.C., 2013*
  • Adenovirus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Teva Pharmaceutical Industries Limited, 2013*
  • Adenovirus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Viracor-IBT Laboratories, Inc., 2013*
  • Adenovirus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Qiagen N.V., 2013*
  • Adenovirus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Baylor College of Medicine, 2013*
  • Adenovirus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2013*
  • Adenovirus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Lifelong Vision Foundation, 2013*
  • Adenovirus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Osaka City University, 2013*
  • Adenovirus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Tokyo Hospital, 2013*
  • Adenovirus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical College of Wisconsin, 2013*
  • Adenovirus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Federal University of Sao Paulo, 2013*
  • Adenovirus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2013*

List of Figures

  • Adenovirus Infections Therapeutics Market, Global, Clinical Trials by Zone (%), 2013*
  • Adenovirus Infections Therapeutics Market, Global, Clinical Trials by Top Countries, 2013*
  • Adenovirus Infections Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013*
  • Adenovirus Infections Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2013*
  • Adenovirus Infections Therapeutics Clinical Trials, Europe, Top Countries (%), 2013*
  • Adenovirus Infections Therapeutics Clinical Trials, BRIC Countries (%), 2013*
  • Adenovirus Infections Therapeutics Clinical Trials, G7 Countries (%), 2013*
  • Adenovirus Infections Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013*
  • Adenovirus Infections Therapeutics Clinical Trials, E7 Countries (%), 2013*
  • Adenovirus Infections Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013*
  • Adenovirus Infections Therapeutics Market, Global, Clinical Trials by Phase (%), 2013*
  • Adenovirus Infections Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013*
  • Adenovirus Infections Therapeutics Market, Global, Clinical Trials by Trial Status, 2013*
  • Adenovirus Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012
  • Adenovirus Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2013*
  • Adenovirus Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013*
  • Adenovirus Infections Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013*
  • GlobalData Methodology
Back to Top